New data on efficacy of valaciclovir in secondary prevention of maternal-fetal transmission of CMV.
C EgloffJ SibiudeC Vauloup-FellousA BenachiE BouthryF BiquardAmeth Hawkins-VillarrealN Houhou-FidouhL MandelbrotAlexandre Joseph VivantiOlivier PiconePublished in: Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology (2022)
VCV treatment of pregnant women with primary CMV infection in the first and second trimesters reduces the risk of transmission to the fetus. This article is protected by copyright. All rights reserved.